(1->4)-beta-D-glucan multiple interactions ISO RGD:1314491 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BLVRB mRNA CTD PMID:36331819 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1314491 6480464 [3 more ... CTD PMID:23457121 , PMID:32352317 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314490 6480464 Tetrachlorodibenzodioxin results in increased expression of BLVRB mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BLVRB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BLVRB mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314491 6480464 Tetrachlorodibenzodioxin results in increased expression of BLVRB mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314491 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of BLVRB mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BLVRB promoter] CTD PMID:16214954 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314491 6480464 Tetrachlorodibenzodioxin affects the expression of BLVRB mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol increases expression ISO RGD:1314491 6480464 n-butoxyethanol results in increased expression of BLVRB mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:1314490 6480464 Lactic Acid results in decreased expression of BLVRB mRNA CTD PMID:30851411 2-tert-butylhydroquinone increases expression ISO RGD:1314491 6480464 2-tert-butylhydroquinone results in increased expression of BLVRB mRNA CTD PMID:16014739 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1314491 6480464 [3 more ... CTD PMID:23457121 4,4'-sulfonyldiphenol increases expression ISO RGD:1314490 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of BLVRB protein CTD PMID:34186270 4-hydroxynon-2-enal increases expression ISO RGD:1314491 6480464 4-hydroxy-2-nonenal results in increased expression of BLVRB mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine affects expression ISO RGD:1314490 6480464 Decitabine affects the expression of BLVRB mRNA CTD PMID:23300844 5-fluorouracil affects response to substance ISO RGD:1314490 6480464 BLVRB protein affects the susceptibility to Fluorouracil CTD PMID:16217747 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of BLVRB mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:1314490 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of BLVRB mRNA] CTD PMID:21233418 all-trans-retinoic acid increases expression ISO RGD:1314490 6480464 Tretinoin results in increased expression of BLVRB mRNA CTD PMID:16249480 andrographolide multiple interactions ISO RGD:1314491 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA CTD PMID:19737545 aristolochic acid A increases expression ISO RGD:1314490 6480464 aristolochic acid I results in increased expression of BLVRB mRNA CTD PMID:33212167 arsenous acid increases expression ISO RGD:1314490 6480464 Arsenic Trioxide results in increased expression of BLVRB mRNA CTD PMID:15725085 more ... asperentin increases expression ISO RGD:1314491 6480464 cladosporin results in increased expression of BLVRB mRNA CTD PMID:21356202 benzo[a]pyrene increases expression ISO RGD:1314490 6480464 Benzo(a)pyrene results in increased expression of BLVRB mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene increases expression ISO RGD:1314491 6480464 Benzo(a)pyrene results in increased expression of BLVRB mRNA CTD PMID:19770486 more ... beta-naphthoflavone multiple interactions ISO RGD:1314491 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA CTD PMID:19737545 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1314491 6480464 Diethylhexyl Phthalate results in increased expression of BLVRB mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1314491 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of BLVRB mRNA] CTD PMID:19850644 bisphenol A increases expression ISO RGD:1314491 6480464 bisphenol A results in increased expression of BLVRB mRNA CTD PMID:22687993 bisphenol A affects expression ISO RGD:1314490 6480464 bisphenol A affects the expression of BLVRB mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BLVRB mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:1314490 6480464 bisphenol B results in increased expression of BLVRB protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1314490 6480464 bisphenol F results in increased expression of BLVRB protein CTD PMID:34186270 bortezomib increases expression ISO RGD:1314490 6480464 Bortezomib results in increased expression of BLVRB mRNA CTD PMID:20977926 buspirone increases expression EXP 6480464 Buspirone results in increased expression of BLVRB mRNA CTD PMID:24136188 buta-1,3-diene increases expression ISO RGD:1314491 6480464 1, 3-butadiene results in increased expression of BLVRB mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO RGD:1314490 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB protein CTD PMID:33040242 cadmium dichloride multiple interactions ISO RGD:1314490 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB protein CTD PMID:33040242 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BLVRB protein CTD PMID:22081424 calycosin increases expression ISO RGD:1314490 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone results in increased expression of BLVRB protein CTD PMID:24455688 cannabidiol increases expression ISO RGD:1314490 6480464 Cannabidiol results in increased expression of BLVRB mRNA CTD PMID:31518892 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of BLVRB mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:1314490 6480464 CGP 52608 promotes the reaction [RORA protein binds to BLVRB gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:1314491 6480464 Chloroprene results in increased expression of BLVRB mRNA CTD PMID:23125180 ciglitazone multiple interactions ISO RGD:1314490 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of BLVRB mRNA CTD PMID:16197558 cisplatin increases expression ISO RGD:1314490 6480464 Cisplatin results in increased expression of BLVRB mRNA CTD PMID:27594783 cisplatin increases expression ISO RGD:1314491 6480464 Cisplatin results in increased expression of BLVRB mRNA CTD PMID:34626751 cisplatin affects expression ISO RGD:1314490 6480464 Cisplatin affects the expression of BLVRB mRNA CTD PMID:23300844 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of BLVRB protein CTD PMID:16470657 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of BLVRB mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1314490 6480464 [NSC 689534 binds to Copper] which results in increased expression of BLVRB mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1314490 6480464 [NSC 689534 binds to Copper] which results in increased expression of BLVRB mRNA CTD PMID:20971185 copper(II) chloride increases expression ISO RGD:1314490 6480464 cupric chloride results in increased expression of BLVRB mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1314490 6480464 Copper Sulfate results in increased expression of BLVRB mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1314490 6480464 Coumestrol results in increased expression of BLVRB mRNA CTD PMID:19167446 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of BLVRB protein CTD PMID:9006340 cyclosporin A decreases expression ISO RGD:1314491 6480464 Cyclosporine results in decreased expression of BLVRB mRNA CTD PMID:25270620 cyclosporin A increases expression ISO RGD:1314490 6480464 Cyclosporine results in increased expression of BLVRB mRNA CTD PMID:20106945 more ... diarsenic trioxide increases expression ISO RGD:1314490 6480464 Arsenic Trioxide results in increased expression of BLVRB mRNA CTD PMID:15725085 more ... dibutyl phthalate decreases expression ISO RGD:1314491 6480464 Dibutyl Phthalate results in decreased expression of BLVRB mRNA CTD PMID:17361019 dibutyl phthalate increases expression ISO RGD:1314491 6480464 Dibutyl Phthalate results in increased expression of BLVRB mRNA CTD PMID:21266533 diethyl maleate increases expression ISO RGD:1314491 6480464 diethyl maleate results in increased expression of BLVRB mRNA CTD PMID:25270620 , PMID:34626751 dorsomorphin multiple interactions ISO RGD:1314490 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314490 6480464 Doxorubicin results in increased expression of BLVRB mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1314490 6480464 Selenium results in increased expression of BLVRB mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BLVRB mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1314490 6480464 entinostat results in increased expression of BLVRB mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1314490 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1314491 6480464 epoxiconazole results in decreased expression of BLVRB mRNA CTD PMID:35436446 ethanol decreases activity EXP 6480464 Ethanol results in decreased activity of BLVRB protein CTD PMID:11173977 ethanol affects expression ISO RGD:1314491 6480464 Ethanol affects the expression of BLVRB mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1314490 6480464 Ethyl Methanesulfonate results in increased expression of BLVRB mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of BLVRB mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of BLVRB mRNA CTD PMID:24136188 formaldehyde increases expression ISO RGD:1314490 6480464 Formaldehyde results in increased expression of BLVRB mRNA CTD PMID:23649840 furan decreases expression EXP 6480464 furan results in decreased expression of BLVRB mRNA CTD PMID:26194646 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of BLVRB mRNA CTD PMID:24136188 hypochlorous acid increases expression ISO RGD:1314491 6480464 Hypochlorous Acid results in increased expression of BLVRB mRNA CTD PMID:19376150 inulin multiple interactions ISO RGD:1314491 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BLVRB mRNA CTD PMID:36331819 isotretinoin decreases expression ISO RGD:1314490 6480464 Isotretinoin results in decreased expression of BLVRB mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1314490 6480464 Ivermectin results in decreased expression of BLVRB protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:1314491 6480464 lead acetate results in increased expression of BLVRB mRNA CTD PMID:25270620 lead(0) affects expression ISO RGD:1314490 6480464 Lead affects the expression of BLVRB mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1314490 6480464 Lead affects the expression of BLVRB mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of BLVRB mRNA CTD PMID:24136188 Licochalcone B increases expression ISO RGD:1314490 6480464 licochalcone B results in increased expression of BLVRB mRNA CTD PMID:33647349 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of BLVRB protein CTD PMID:27018092 lipopolysaccharide increases expression ISO RGD:1314491 6480464 Lipopolysaccharides results in increased expression of BLVRB mRNA CTD PMID:21356202 menadione increases expression ISO RGD:1314491 6480464 Vitamin K 3 results in increased expression of BLVRB mRNA CTD PMID:25270620 methyl methanesulfonate increases expression ISO RGD:1314490 6480464 Methyl Methanesulfonate results in increased expression of BLVRB mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1314490 6480464 methylmercuric chloride results in increased expression of BLVRB mRNA CTD PMID:28001369 microcystin-LR increases expression ISO RGD:1314491 6480464 cyanoginosin LR results in increased expression of BLVRB mRNA CTD PMID:17654400 mycotoxin increases expression ISO RGD:1314491 6480464 Mycotoxins results in increased expression of BLVRB mRNA CTD PMID:21356202 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1314491 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BLVRB mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1314490 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BLVRB mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1314491 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA CTD PMID:19840844 N-nitrosodiethylamine multiple interactions ISO RGD:1314491 6480464 [3 more ... CTD PMID:23457121 , PMID:24535843 N-nitrosodimethylamine increases expression ISO RGD:1314490 6480464 Dimethylnitrosamine results in increased expression of BLVRB mRNA CTD PMID:17547211 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of BLVRB protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of BLVRB mRNA CTD PMID:24136188 neoechinulin A increases expression ISO RGD:1314491 6480464 neoechinulin A results in increased expression of BLVRB mRNA CTD PMID:21356202 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of BLVRB mRNA CTD PMID:24136188 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of BLVRB protein CTD PMID:19260726 ochratoxin A decreases expression ISO RGD:1314490 6480464 ochratoxin A results in decreased expression of BLVRB mRNA CTD PMID:32905824 okadaic acid multiple interactions ISO RGD:1314491 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA CTD PMID:19840844 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of BLVRB mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BLVRB mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1314491 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BLVRB mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of BLVRB mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:1314490 6480464 p-Chloromercuribenzoic Acid results in increased expression of BLVRB mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1314490 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA CTD PMID:27188386 pentachlorophenol increases expression ISO RGD:1314491 6480464 Pentachlorophenol results in increased expression of BLVRB mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1314490 6480464 perfluorooctane sulfonic acid results in increased expression of BLVRB mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1314491 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BLVRB mRNA more ... CTD PMID:36331819 perfluorooctanoic acid multiple interactions ISO RGD:1314491 6480464 PPARA promotes the reaction [perfluorooctanoic acid results in decreased expression of BLVRB mRNA] CTD PMID:20118188 perfluorooctanoic acid increases expression ISO RGD:1314491 6480464 perfluorooctanoic acid results in increased expression of BLVRB mRNA CTD PMID:20118188 phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of BLVRB mRNA CTD PMID:17616710 phenobarbital multiple interactions ISO RGD:1314491 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BLVRB mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of BLVRB mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1314491 6480464 Phenobarbital results in increased expression of BLVRB mRNA CTD PMID:19482888 phosgene affects expression ISO RGD:1314491 6480464 Phosgene affects the expression of BLVRB mRNA CTD PMID:16300373 pirinixic acid increases expression ISO RGD:1314491 6480464 pirinixic acid results in increased expression of BLVRB mRNA CTD PMID:18301758 , PMID:23811191 quercetin affects expression EXP 6480464 Quercetin affects the expression of BLVRB mRNA CTD PMID:18178720 rac-lactic acid decreases expression ISO RGD:1314490 6480464 Lactic Acid results in decreased expression of BLVRB mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BLVRB mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1314490 6480464 Rotenone results in increased expression of BLVRB mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1314490 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1314490 6480464 Selenium results in increased expression of BLVRB mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:1314491 6480464 Silver results in increased expression of BLVRB mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1314491 6480464 Silver results in increased expression of BLVRB mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1314491 6480464 sodium arsenite results in increased expression of BLVRB mRNA CTD PMID:16014739 , PMID:25270620 sodium arsenite increases expression ISO RGD:1314490 6480464 sodium arsenite results in increased expression of BLVRB mRNA CTD PMID:36586010 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BLVRB protein CTD PMID:29459688 sodium dodecyl sulfate decreases expression ISO RGD:1314490 6480464 Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA CTD PMID:31734321 sterigmatocystin increases expression ISO RGD:1314491 6480464 Sterigmatocystin results in increased expression of BLVRB mRNA CTD PMID:21356202 succimer multiple interactions ISO RGD:1314491 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BLVRB mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1314490 6480464 Sunitinib results in increased expression of BLVRB mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1314490 6480464 Temozolomide results in decreased expression of BLVRB mRNA CTD PMID:31758290 tetrachloromethane decreases expression ISO RGD:1314491 6480464 Carbon Tetrachloride results in decreased expression of BLVRB mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BLVRB mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BLVRB mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BLVRB mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1314491 6480464 Trichloroethylene results in increased expression of BLVRB mRNA CTD PMID:28973375 triclosan increases expression ISO RGD:1314490 6480464 Triclosan results in increased expression of BLVRB mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:1314491 6480464 triptonide results in decreased expression of BLVRB mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1314490 6480464 tris(2-butoxyethyl) phosphate affects the expression of BLVRB mRNA CTD PMID:29024780 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of BLVRB mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1314491 6480464 Valproic Acid affects the expression of BLVRB mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1314490 6480464 Valproic Acid results in increased expression of BLVRB mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:1314490 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314491 6480464 Valproic Acid results in increased expression of BLVRB mRNA CTD PMID:20546886 , PMID:21427059 valproic acid affects expression ISO RGD:1314490 6480464 Valproic Acid affects the expression of BLVRB mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of BLVRB mRNA CTD PMID:20566332 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BLVRB mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1314490 6480464 vorinostat results in increased expression of BLVRB mRNA, vorinostat results in increased expression of BLVRB protein CTD PMID:17593366 , PMID:27188386
